Navigation Links
Decision Resources' Updated Rheumatoid Arthritis Report Now Includes Forecast for Rigel Pharmaceuticals' Fostamatinib Disodium
Date:8/6/2009

Decision Resources (www.decisionresources.com) is a world leader in market research publications, advisory services and consulting designed to help clients shape strategy, allocate resources and master their chosen markets. Decision Resources is a Decision Resources, Inc. company.

About Decision Resources, Inc.

Decision Resources, Inc. is a cohesive portfolio of companies that offers best-in-class, high-value information and insights on important sectors of the healthcare industry. Clients rely on this analysis and data to make informed decisions. Please visit Decision Resources, Inc. at www.DecisionResourcesInc.com.

All company, brand, or product names contained in this document may be trademarks or registered trademarks of their respective holders.

    For more information, contact:

    Decision Resources                         Decision Resources, Inc.
    Christopher Comfort                        Elizabeth Marshall
    781-296-2597                               781-296-2563
    ccomfort@dresources.com                    emarshall@dresources.com


'/>"/>
SOURCE Decision Resources
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. BCBSGA Announces Decision to Cover H1N1 Vaccine Administration
2. PET can help guide treatment decisions for a common pediatric cancer
3. WellPoint Announces Decision to Cover H1N1 Vaccine Administration
4. United States Patent Office Issues Decision in Re-examination Proceedings
5. Providence Service Corporation Comments on U.S. Court of Appeals Decision to Uphold Federal Injunction Blocking Californias 10% Cut in Medi-Cal Payments
6. Stem Cell Decision Opens New Doors, May Spur More Research
7. TriServ Likely to Protest Decision
8. Communicating science to decision makers
9. Brain section multitasks, handling phonetics and decision-making
10. The decision about the incision: Is midline or transverse better for abdominal surgery?
11. Jeff Stewart Joins Decision Resources, Inc. as Chief Information Officer

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/23/2009)...ANTACLARA,Calif.,Nov.23/PRNewswire-FirstCall/--New...tictechnologyprovider,announcedtodaythatCEO,Dr.Bra...tthe2ndAnnualLDMICROConferenceonThursday,December3..., Companymanagementwillbeavailableforone-on-onem...3rd.PleasecontactBrettAimeeMaasat(646)536-7331or b...
(Date:11/23/2009)...ANDIEGO,Calif.,Nov.23/PRNewswire-FirstCall/--Orexi...uncedthatfourseniorexecutiveshavejoinedtheorganiza...edevelopmentofitsobesityfranchise.Additionstothema...egulatoryAffairs;SuzanneMcDonald,HeadofManagedMark...GlobalContraveProgram;andWhedyWang,Ph.D,MPH,Headof...
(Date:11/23/2009)... Recognized as Best New Technology...oftware , Radnor, PA (PRW...;s fastest-growing Business Intelligence (BI) soft...ed with the Healthcare IT Innovation™ Award ...ts flagship product, QlikView. The award was prese...
(Date:11/23/2009)... Information about Oxycodone use i... DopeStats.com. The new site is a statistical data...s of Oxycodone in each county in the United States...e used the drug for recreational or medicinal use....) November 23, 2009 -- Legal and illegal Oxycodon...
(Date:11/23/2009)...ORTHANDOVER,Mass.,Nov.23/PRNewswire/--Thistimeofye...nxiety.Oftenthesefeelings,bothpositiveandnegative,...faceit,therearelotsofopportunitiestodosoallseasonl...fmom,sapplepie,buthowmanyofusstopthere?"Thatpieoft...tholidayseasonafterholidayseasontellingourselvesto...
Breaking Medicine News(10 mins):Health News:NewCardio, Inc. to Present at 2nd Annual LD MICRO Conference 2Health News:NewCardio, Inc. to Present at 2nd Annual LD MICRO Conference 3Health News:Four Senior Executives Join Orexigen(R) Therapeutics Management Team 2Health News:Four Senior Executives Join Orexigen(R) Therapeutics Management Team 3Health News:Four Senior Executives Join Orexigen(R) Therapeutics Management Team 4Health News:Four Senior Executives Join Orexigen(R) Therapeutics Management Team 5Health News:QlikTech Wins Healthcare IT Innovation™ Award 2Health News:QlikTech Wins Healthcare IT Innovation™ Award 3Health News:QlikTech Wins Healthcare IT Innovation™ Award 4Health News:DopeStats.com Provides Statistics on Oxycodone Abused in Non-Medical Purposes 2Health News:Tis' the Season to Eat and Eat More! 2
... from the University of North Carolina have identi... or migration. // The protein, CIB1, or calci...discovered at UNC in 1997 as a blood platelet prot...pment, new blood vessel formation and wound healin...
...-old boy in a West Bengal town is said to be in sl...his Rip Van Winkle act. // Reports Saturday s...ict was an active and playful boy of eight until 1...d for feeding and answering nature's call. ...
...ry active leisure time can reduce the chances of h...chemic stroke. Researchers from National Public He...these findings in the journal Stroke: Journal of t...of them healthy and without any previous history o...
...als have devised a new system that ranks foods acc...as designed and developed// by a panel of independ... from the food industry and consumer groups, as we...has evolved through consultations over the last fe...
... from Douglas Hospital Research Center in Montreal...are more equipped to deal with stressful situation...though the benefits of breast-feeding are well est...ood for the mothers as such mothers will be able t...
...mains one of the significant health problems to be.... It requires a multi faceted approach. A protein-...ype II diabetes. A recent study shows that co...ividuals control their blood sugar levels after a ...
Other Medicine News:Health News:Identified Protein To Inhibit Cell Migration 2Health News:Physical Activity During Leisure Can Reduce Risk Of Stroke 2Health News:Nutrient Profiling System Launched By Food Officials in UK 2Health News:Breastfeeding Lowers Maternal Stress 2Health News:Increasing Insulin Response In Type 2 Diabetics With New Protein Mixture 2
(Date:11/23/2009)...23/PRNewswire-FirstCall/--CeptionTherapeutics,Inc....n,Inc.(Nasdaq: CEPH )todayannouncedresultsfromaPha...atreatmentforpediatriceosinophilicesophagitis(EoE)...rimaryendpointsofchangesinesophagealeosinophilleve...atpatientstreatedwithCINQUILshowedastatisticallysi...
(Date:11/23/2009)...re/--AdvancedSterilizationProducts(ASP),aleadinggl...odaytheacquisitionbyitsFrenchaffiliate,ApsisS.A.S....vedisinfectionprocessesandtechnologiestopreventhea...renotdisclosed. ,, GlosterEuropedesignsandmarke...videsdisinfectionofpatientenvironmentssuchashospit...
(Date:11/20/2009)...wire/ -- The United States Court of Appeals for t...ruling yesterday, approving a settlement in the lo...tical litigation against AstraZeneca Pharmaceutica...i-bin/prnh/20080317/AQM144LOGO ) ,, The ruling ...rchased the pharmaceutical giant,s prostate cancer...
Breaking Medicine Technology:Ception Therapeutics and Cephalon Provide Initial Results of a Phase IIb/III Study of CINQUIL in Pediatric Eosinophilic Esophagitis 2Ception Therapeutics and Cephalon Provide Initial Results of a Phase IIb/III Study of CINQUIL in Pediatric Eosinophilic Esophagitis 3Ception Therapeutics and Cephalon Provide Initial Results of a Phase IIb/III Study of CINQUIL in Pediatric Eosinophilic Esophagitis 4ASP Announces Acquisition of Gloster Europe to Help Reduce Infections in Healthcare Facilities 2U.S. Court of Appeals Upholds AstraZeneca AWP Settlement 2U.S. Court of Appeals Upholds AstraZeneca AWP Settlement 3Cooper University Hospital Reduces Costs and Enhances Patient Care with IP Telephony and Wireless Site Survey 54055 1Cooper University Hospital Reduces Costs and Enhances Patient Care with IP Telephony and Wireless Site Survey 54055 2Cooper University Hospital Reduces Costs and Enhances Patient Care with IP Telephony and Wireless Site Survey 54055 3First Ever Downloadable Safety in the Home Guides Available Now From VisionAWARE org 54051 1First Ever Downloadable Safety in the Home Guides Available Now From VisionAWARE org 54051 2McKesson Expands Pharmacy Automation Product Portfolio to Include I V Therapy 13473 1McKesson Expands Pharmacy Automation Product Portfolio to Include I V Therapy 13473 2McKesson Expands Pharmacy Automation Product Portfolio to Include I V Therapy 13473 3
... SyntheMed, Inc. (OTC,Bulletin Board: SYMD), a bi...commercialization of anti-adhesion, drug delivery ...day that REPEL-CV(R), the company,s,bioresorbable ...ns,following cardiac surgery, has received Health ...undergo open heart surgery. REPEL-CV will be,marke...
..., July 14 MAP,Pharmaceuticals, Inc. (Nasdaq: MAP...linical program to evaluate MAP0004 as a potential...ed and self-administered at home using MAP,Pharmac...pany,s prior Phase,2 efficacy study, MAP0004 provi...ef sustained through at least 24 hours. The study ...
Other Medicine Technology:SyntheMed Receives Canadian Approval for REPEL-CV(R) 2MAP Pharmaceuticals Initiates Phase 3 Clinical Trial in Patients With Migraine 2MAP Pharmaceuticals Initiates Phase 3 Clinical Trial in Patients With Migraine 3MAP Pharmaceuticals Initiates Phase 3 Clinical Trial in Patients With Migraine 4
... reference laboratory and a worldwide leader in in... offers an extensive test menu of highly complex a...athology. Owned by the University of Utah, ARUP La...nation's university teaching hospitals and childre...
... reference laboratory and a worldwide leader in in... offers an extensive test menu of highly complex a...athology. Owned by the University of Utah, ARUP La...nation's university teaching hospitals and childre...
... reference laboratory and a worldwide leader in in... offers an extensive test menu of highly complex a...athology. Owned by the University of Utah, ARUP La...nation's university teaching hospitals and childre...
... reference laboratory and a worldwide leader in in... offers an extensive test menu of highly complex a...athology. Owned by the University of Utah, ARUP La...nation's university teaching hospitals and childre...
Medicine Products: